Regenerative Medical Technology Group Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $-6.1K | $-6.1K | — | — |
| FY2018 | $-244.6K | $-248.6K | $4.0K | — |
| FY2019 | $-362.3K | $-462.3K | $100.0K | $1.2M |
| FY2020 | $-322.7K | $-422.7K | $100.0K | — |
| FY2021 | $-9.9M | $-9.9M | — | — |
| FY2022 | $-1.1M | $-1.3M | $198.4K | — |
| FY2023 | $-419.2K | $-804.8K | $385.6K | — |
| FY2024 | $850.7K | $635.3K | $215.4K | — |
| FY2025 | $-706.5K | $-1.3M | $602.6K | — |